Table 1. Baseline characteristics and urine metals.
Categorical values n (%); continuous values mean (std); baseline metals mean (CI); estimated Glomerular Filtration Rate (eGRF) was calculated by the Modification of Diet in Renal Disease Study equation
| Variables | (n=10) |
| Demographics | |
| Age | 76 ± 9 |
| Sex, female | 4 (40%) |
| Smoking History | 3 (30%) |
| Comorbidities | |
| Hypertension | 10 (100%) |
| Diabetes Mellitus | 10 (100%) |
| Hyperlipidemia | 6 (60%) |
| Cerebrovascular Events | 0 |
| Coronary Artery Disease | 7 (70%) |
| Coronary Artery Bypass Graft | 3 (30%) |
| Ulcer or Gangrene | 7 (70%) |
| Peripheral Vascular History | |
| History of Amputations | 5 (50%) |
| Lower Extremity Revascularizations | 10 (100%) |
| Society of Vascular Surgery Wlfl High-risk Staging | |
| High Risk (clinical stage 4) | 6 (60%) |
| Moderate Risk (clinical stage 3) | 3 (30%) |
| Low Risk (clinical stage 2) | 1 (10%) |
| Renal Function | |
| Creatinine (mg/dL) | 0.92 ± 0.22 |
| *Estimated Glomerular Filtration Rate (mL/min/1.73 m2) | 77.6 ± 16.4 |
| Medications | |
| Insulin | 5 (50%) |
| Beta-blockers | 5 (50%) |
| Aspirin | 6 (60%) |
| Clopidogrel | 8 (80%) |
| Angiotensin Converting Enzyme/Angiotensin Receptor Blocker Inhibitor | 7 (70%) |
| Statin | 7 (70%) |
| Baseline Urine Metals (μg of metal per g creatinine) | |
| Pre-infusion Cadmium | 0.75 (-0.074,1.57) |
| Post-infusion Cadmium | 4.25 (2.73,5.77) |
| Pre-infusion Lead | 0.68 (0.24,1.12) |
| Post-infusion Lead | 18.75(9.70,27.80) |